Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03047135
Title	Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis
Recruitment	Active, not recruiting
Gender	male
Phase	Phase II
Variant Requirements	Yes
Sponsors	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications	prostate adenocarcinoma
Therapies	Olaparib
Age Groups:	adult \| senior
Covered Countries	USA